Enterprise Value
192.1M
Cash
14.96M
Avg Qtr Burn
-5.334M
Short % of Float
12.12%
Insider Ownership
17.32%
Institutional Own.
50.66%
Qtr Updated
06/30/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
PEDMARK™ (sodium thiosulfate) Details Hearing loss | Approved Quarterly sales |